Accessibility Menu
Redwood Scientific Technologies logo

Redwood Scientific Technologies(OTC) RSCI

Market Cap$2.27MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2009)-100%
5 Year-89%
1 Year-84%
1 Month+0%
$0.01
+0%
+0.00Today
Redwood Scientific Technologies last closing stock price
MetricPriceDate
Last closeUSD 0.012026-07-09
Redwood Scientific Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.012026-07-02
1 month+0%USD 0.012026-05-14
3 month+11,000%USD 0.002026-04-06
Year to date+0%USD 0.012025-12-23
1 year-84.14%USD 0.072025-05-13
3 year-95.56%USD 0.252023-07-07
5 year-88.9%USD 0.102021-07-09
Since inception-100%USD 10,134.632009-10-22

Redwood Scientific Technologies Financials at a Glance

Market Cap

$2.27MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$3.42M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-4.39 (Low)

Price

$0.01

Volume

1,106

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.07

Estimated Earnings Date

N/A

RSCI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Redwood Scientific Technologies

Redwood Scientific Technologies, Inc. specializes in developing and marketing over-the-counter FDA registered drugs utilizing innovative oral strip delivery technology. Based in Claremont, California, the company operates within the healthcare sector, focusing on pharmaceuticals.

Products and Services
  • Over-the-counter FDA registered drugs
  • Oral strip delivery technology for medication
  • Innovative healthcare solutions targeting consumer needs
Growth Outlook
  • Market demand for convenient drug delivery systems is increasing
  • Potential for expansion into new therapeutic areas
  • Focus on enhancing product offerings to capture market share
Financial Highlights
  • Recent quarterly net income of -$2,494,666
  • Trailing twelve months (TTM) cash and cash equivalents of $271,471
  • Current ratio of 0.60 indicates liquidity challenges
Redwood Scientific Technologies, Inc. is positioned in a growing market with a focus on innovative drug delivery methods. The company's recent financial performance shows a net loss, reflecting ongoing operational challenges. However, the increasing demand for convenient healthcare solutions presents opportunities for growth. The current ratio suggests a need for improved liquidity management, which could be addressed through strategic initiatives. Overall, Redwood Scientific Technologies, Inc. remains a company to watch as it navigates the evolving pharmaceutical landscape.
AI Generated • Jul 18, 2026

Industry

Personal Products

Sector

Consumer Staples

CEO

Jason Cardiff

Website

www.redwoodsci.co

Headquarters

Claremont, CA 91711, US

RSCI Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

2058.35%

Return on Capital

N/A

Return on Assets

-1174.45%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.27MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

204.94M

Volume

1.11K

Avg. Volume

21.29

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$3.42M

EBITDA

-$3.42M

Operating Cash Flow

-$1.07M

Capital Expenditure

$4.00

Free Cash Flow

-$1.07M

Cash & ST Invst.

$271.47K

Total Debt

$0.00

Redwood Scientific Technologies Performance Analysis

Redwood Scientific Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 0N/A
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
Redwood Scientific Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12023-03-31N/A
Q22023-06-30N/A
Q32023-09-30N/A
Q42023-12-31N/A
Redwood Scientific Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD 0.00N/A
20222022-12-31USD -0.00N/A
20232023-12-31USD -0.022150.0%
Redwood Scientific Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12023-03-31-37.5%
Q22023-06-30-27.3%
Q32023-09-30-64.3%
Q42023-12-31-430.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2023YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$2.27MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$454.98K

N/A

Employees

5

N/A

Net Income

-$2.49M

-1635.9%

EBITDA

-$2.49M

-1635.9%

Quarterly Fundamentals

Name
Q4 2023YOY CHG

Total Cash

$271.47K

+95.9%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-11.74%

N/A

Return on Invested Capital

17.89%

N/A

Free Cash Flow

-$352.94K

N/A

Operating Cash Flow

-$352.94K

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SYUPAnbc, Inc.
$0.00+0.00%
MILCMillennium Sustainable Ventures Corp.
$0.00+0.00%
GENXGenex Pharmaceutical, Inc.
$0.00+0.00%
AAXTAamaxan Transport Group, Inc.
$0.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.25+0.10%
NOKNokia
$9.28+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.24-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$63.40-0.01%

Questions About RSCI

What is the current price of Redwood Scientific Technologies?

Redwood Scientific Technologies is trading at $0.01 per share.

What is the 52-week range for Redwood Scientific Technologies?

Over the past 52 weeks, Redwood Scientific Technologies has traded between $0.00 and $0.07.

How much debt does Redwood Scientific Technologies have?

As of the most recent reporting period, Redwood Scientific Technologies reported total debt of $0.00.

How much cash does Redwood Scientific Technologies have on hand?

Redwood Scientific Technologies reported $271.47K in cash and cash equivalents in its most recent financial results.

What is Redwood Scientific Technologies’s dividend yield?

Redwood Scientific Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services